Amyloid Cancer & Amyloid Cancer Research Paper :BETAAMYLOID.BLOGSPOT.COM

Amyloid Cancer

Amyloid Cancer: Research Paper on Amyloid Cancer for Month of October 2009

Namanja HA, Emmert D, Pires MM, Hrycyna CA, Chmielewski J. Inhibition of human P-glycoprotein transport and substrate binding using a galantamine dimer. Biochem Biophys Res Commun. 2009 Oct 30;388(4):672-6. Amyloid Cancer

Mouton PR, Chachich ME, Quigley C, Spangler E, Ingram DK. Caloric restriction attenuates amyloid deposition in middle-aged dtg APP/PS1 mice. Neurosci Lett. 2009 Oct 30;464(3):184-7. Amyloid Cancer  

Zhang JJ, Zhang RF, Meng XK. Protective effect of pyrroloquinoline quinone against Abeta-induced neurotoxicity in human neuroblastoma SH-SY5Y cells. Neurosci Lett. 2009 Oct 30;464(3):165-9. Amyloid Cancer  

Beeler N, Riederer BM, Waeber G, Abderrahmani A. Role of the JNK-interacting protein 1/islet brain 1 in cell degeneration in Alzheimer disease and diabetes. Brain Res Bull. 2009 Oct 28;80(4-5):274-81. Amyloid Cancer  

Giuliani F, Vernay A, Leuba G, Schenk F. Decreased behavioral impairments in an Alzheimer mice model by interfering with TNF-alpha metabolism. Brain Res Bull. 2009 Oct 28;80(4-5):302-8. Amyloid Cancer  

Morita M, Osoda K, Yamazaki M, Shirai F, Matsuoka N, Arakawa H, Nishimura S. Effects of non-steroidal anti-inflammatory drugs on Abeta deposition in Abeta(1-42) transgenic C. elegans. Brain Res. 2009 Oct 27;1295:186-91. Amyloid Cancer  

Hou JF, Cui J, Yu LC, Zhang Y. Intracellular amyloid induces impairments on electrophysiological properties of cultured human neurons. Neurosci Lett. 2009 Oct 25;462(3):294-9. Amyloid Cancer  

Peng Y, Xing C, Xu S, Lemere CA, Chen G, Liu B, Wang L, Feng Y, Wang X. l-3-n-butylphthalide improves cognitive impairment induced by intracerebroventricular infusion of amyloid-beta peptide in rats. Eur J Pharmacol. 2009 Oct 25;621(1-3):38-45. Amyloid Cancer  

Nielsen AL. The coat protein complex II, COPII, protein Sec13 directly interacts with presenilin-1. Biochem Biophys Res Commun. 2009 Oct 23;388(3):571-5. Amyloid Cancer  

Ono M, Watanabe R, Kawashima H, Cheng Y, Kimura H, Watanabe H, Haratake M, Saji H, Nakayama M. Fluoro-pegylated Chalcones as Positron Emission Tomography Probes for in Vivo Imaging of beta-Amyloid Plaques in Alzheimer's Disease. J Med Chem. 2009 Oct 22;52(20):6394-401. Amyloid Cancer  

Raymond SB, Kumar AT, Boas DA, Bacskai BJ. Optimal parameters for near infrared fluorescence imaging of amyloid plaques in Alzheimer's disease mouse models. Phys Med Biol. 2009 Oct 21;54(20):6201-16. Amyloid Cancer  

Pérez-López FR, Chedraui P, Haya J, Cuadros JL. Effects of the Mediterranean diet on longevity and age-related morbid conditions. Maturitas. 2009 Oct 20;64(2):67-79. Amyloid Cancer  

Li Q, Zhao HF, Zhang ZF, Liu ZG, Pei XR, Wang JB, Li Y. Long-term green tea catechin administration prevents spatial learning and memory impairment in senescence-accelerated mouse prone-8 mice by decreasing Abeta1-42 oligomers and upregulating synaptic plasticity-related proteins in the hippocampus. Neuroscience. 2009 Oct 20;163(3):741-9. Amyloid Cancer  

Kitaguchi H, Tomimoto H, Ihara M, Shibata M, Uemura K, Kalaria RN, Kihara T, Asada-Utsugi M, Kinoshita A, Takahashi R. Chronic cerebral hypoperfusion accelerates amyloid beta deposition in APPSwInd transgenic mice. Brain Res. 2009 Oct 19;1294:202-10. Amyloid Cancer  

Mancino AM, Hindo SS, Kochi A, Lim MH. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited. Inorg Chem. 2009 Oct 19;48(20):9596-8. Amyloid Cancer  

Annies M, Stefani M, Hueber A, Fischer F, Paganetti P. Splicing of intron 3 of human BACE requires the flanking introns 2 and 4. Biochem Biophys Res Commun. 2009 Oct 16;388(2):434-8. Amyloid Cancer  

Pardossi-Piquard R, Böhm C, Chen F, Kanemoto S, Checler F, Schmitt-Ulms G, St George-Hyslop P, Fraser PE. TMP21 transmembrane domain regulates gamma-secretase cleavage. J Biol Chem. 2009 Oct 16;284(42):28634-41. Amyloid Cancer  

Park SA, Shaked GM, Bredesen DE, Koo EH. Mechanism of cytotoxicity mediated by the C31 fragment of the amyloid precursor protein. Biochem Biophys Res Commun. 2009 Oct 16;388(2):450-5. Amyloid Cancer  

Liao MC, Ahmed M, Smith SO, Van Nostrand WE. Degradation of amyloid beta protein by purified myelin basic protein. J Biol Chem. 2009 Oct 16;284(42):28917-25. Amyloid Cancer  

Eggert S, Midthune B, Cottrell B, Koo EH. Induced Dimerization of the Amyloid Precursor Protein Leads to Decreased Amyloid-{beta} Protein Production. J Biol Chem. 2009 Oct 16;284(42):28943-28952. Amyloid Cancer  

Kim M, Suh J, Romano D, Truong MH, Mullin K, Hooli B, Norton D, Tesco G, Elliott K, Wagner SL, Moir RD, Becker KD, Tanzi RE. Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity. Hum Mol Genet. 2009 Oct 15;18(20):3987-96. Amyloid Cancer  

Manczak M, Mao P, Nakamura K, Bebbington C, Park B, Reddy PH. Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease. Hum Mol Genet. 2009 Oct 15;18(20):3876-93. Amyloid Cancer  

Waragai M, Okamura N, Furukawa K, Tashiro M, Furumoto S, Funaki Y, Kato M, Iwata R, Yanai K, Kudo Y, Arai H. Comparison study of amyloid PET and voxel-based morphometry analysis in mild cognitive impairment and Alzheimer's disease. J Neurol Sci. 2009 Oct 15;285(1-2):100-8. Amyloid Cancer  

Pitt J, Roth W, Lacor P, Smith AB, Blankenship M, Velasco P, De Felice F, Breslin P, Klein WL. Alzheimer's-associated Abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal. Toxicol Appl Pharmacol. 2009 Oct 15;240(2):189-97. Amyloid Cancer  

Goodger ZV, Rajendran L, Trutzel A, Kohli BM, Nitsch RM, Konietzko U. Nuclear signaling by the APP intracellular domain occurs predominantly through the amyloidogenic processing pathway. J Cell Sci. 2009 Oct 15;122(Pt 20):3703-14. Amyloid Cancer  

Souter S, Lee G. Microtubule-associated protein tau in human prostate cancer cells: isoforms, phosphorylation, and interactions. J Cell Biochem. 2009 Oct 15;108(3):555-64. Amyloid Cancer  

Vitali M, Venturelli E, Galimberti D, Benerini Gatta L, Scarpini E, Finazzi D. Analysis of the genes coding for subunit 10 and 15 of cytochrome c oxidase in Alzheimer's disease. J Neural Transm. 2009 Oct 14; Amyloid Cancer  

Chakrabarty P, Jansen-West K, Beccard A, Ceballos-Diaz C, Levites Y, Verbeeck C, Zubair AC, Dickson D, Golde TE, Das P. Massive gliosis induced by interleukin-6 suppresses A{beta} deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB J. 2009 Oct 14; Amyloid Cancer  

Jagust WJ, Landau SM, Shaw LM, Trojanowski JQ, Koeppe RA, Reiman EM, Foster NL, Petersen RC, Weiner MW, Price JC, Mathis CA, Alzheimer's Disease Neuroimaging Initiative. Relationships between biomarkers in aging and dementia. Neurology. 2009 Oct 13;73(15):1193-9. Amyloid Cancer  

Waxman EA, Mazzulli JR, Giasson BI. Characterization of hydrophobic residue requirements for alpha-synuclein fibrillization. Biochemistry. 2009 Oct 13;48(40):9427-36. Amyloid Cancer  

Scheinin NM, Aalto S, Koikkalainen J, Lötjönen J, Karrasch M, Kemppainen N, Viitanen M, Någren K, Helin S, Scheinin M, Rinne JO. Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls. Neurology. 2009 Oct 13;73(15):1186-92. Amyloid Cancer  

Killiany RJ. Isn't amyloid more than just a marker for Alzheimer disease? Neurology. 2009 Oct 13;73(15):1174-5. Amyloid Cancer  

Weller RO, Preston SD, Subash M, Carare RO. Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease. Alzheimers Res Ther. 2009 Oct 12;1(2):6. Amyloid Cancer  

Sala Frigerio C, Kukar TL, Engel PC, Golde TE, Walsh DM. An NSAID-like compound, FT-9, preferentially inhibits gamma-secretase cleavage of APP compared to its effect on APLP1. Biochemistry. 2009 Oct 12; Amyloid Cancer  

Ouberai M, Dumy P, Chierici S, Garcia J. Synthesis and Biological Evaluation of Clicked Curcumin and Clicked KLVFFA Conjugates as Inhibitors of beta-Amyloid Fibril Formation. Bioconjug Chem. 2009 Oct 12; Amyloid Cancer  

Vogt DL, Thomas D, Galvan V, Bredesen DE, Lamb BT, Pimplikar SW. Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain. Neurobiol Aging. 2009 Oct 12; Amyloid Cancer  

Cerdà-Costa N, de la Arada I, Aviles FX, Arrondo JL, Villegas S. The Influence of Aggregation Propensity and Stability on Amyloid Fibril Formation as Studied by FT-IR Spectroscopy and 2D-COS Analysis. Biochemistry. 2009 Oct 12; Amyloid Cancer  

Patel NS, Mathura VS, Bachmeier C, Beaulieu-Abdelahad D, Laporte V, Weeks O, Mullan M, Paris D. Alzheimer's beta-amyloid Peptide Blocks Vascular Endothelial Growth Factor mediated Signaling via Direct Interaction with VEGFR-2. J Neurochem. 2009 Oct 10; Amyloid Cancer  

Kalaitzakis ME, Pearce RK. The morbid anatomy of dementia in Parkinson's disease. Acta Neuropathol. 2009 Oct 10; Amyloid Cancer  

Habert MO, de Souza LC, Lamari F, Daragon N, Desarnaud S, Jardel C, Dubois B, Sarazin M. Brain perfusion SPECT correlates with CSF biomarkers in Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2009 Oct 10; Amyloid Cancer  

Aliaga E, Silhol M, Bonneau N, Maurice T, Arancibia S, Tapia-Arancibia L. Dual response of BDNF to sublethal concentrations of beta-amyloid peptides in cultured cortical neurons. Neurobiol Dis. 2009 Oct 9; Amyloid Cancer  

Ramakrishnan M, Kandimalla KK, Wengenack TM, Howell KG, Poduslo JF. Surface Plasmon Resonance Binding Kinetics of Alzheimer's Disease Amyloid beta Peptide-Capturing and Plaque-Binding Monoclonal Antibodies. Biochemistry. 2009 Oct 9; Amyloid Cancer  

Simpson ER, Herold EM, Buchner J. The folding pathway of the antibody V(L) domain. J Mol Biol. 2009 Oct 9;392(5):1326-38. Amyloid Cancer  

Jeynes B, Provias J. Significant negative correlations between capillary expressed eNOS and Alzheimer lesion burden. Neurosci Lett. 2009 Oct 9;463(3):244-8. Amyloid Cancer  

Hayashi I, Takatori S, Urano Y, Iwanari H, Isoo N, Osawa S, Fukuda MA, Kodama T, Hamakubo T, Li T, Wong PC, Tomita T, Iwatsubo T. Single chain variable fragment against nicastrin inhibits the gamma-secretase activity. J Biol Chem. 2009 Oct 9;284(41):27838-47. Amyloid Cancer  

Hong XP, Peng CX, Wei W, Tian Q, Liu YH, Yao XQ, Zhang Y, Cao FY, Wang Q, Wang JZ. Essential role of tau phosphorylation in adult hippocampal neurogenesis. Hippocampus. 2009 Oct 8; Amyloid Cancer  

Hayashi SI, Sato N, Yamamoto A, Ikegame Y, Nakashima S, Ogihara T, Morishita R. Alzheimer Disease-Associated Peptide, Amyloid {beta}40, Inhibits Vascular Regeneration With Induction of Endothelial Autophagy. Arterioscler Thromb Vasc Biol. 2009 Oct 8; Amyloid Cancer  

Gustaw-Rothenberg KA, Siedlak SL, Bonda DJ, Lerner A, Tabaton M, Perry G, Smith MA. Dissociated Amyloid-beta Antibody Levels as a Serum Biomarker for the Progression of Alzheimer's Disease: A Population-Based Study. Exp Gerontol. 2009 Oct 8; Amyloid Cancer  

Bedrood S, Jayasinghe S, Sieburth D, Chen M, Erbel S, Butler PC, Langen R, Ritzel RA. Annexin A5 Directly Interacts with Amyloidogenic Proteins and Reduces Their Toxicity. Biochemistry. 2009 Oct 8; Amyloid Cancer  

Fuentealba RA, Liu Q, Kanekiyo T, Zhang J, Bu G. Low-density lipoprotein receptor-related protein 1 (LRP1) promotes anti-apoptotic signaling in neurons by activating AKT survival pathway. J Biol Chem. 2009 Oct 8; Amyloid Cancer  

Boado RJ, Lu JZ, Hui EK, Pardridge WM. IgG-single chain Fv fusion protein therapeutic for alzheimer's disease: Expression in CHO cells and pharmacokinetics and brain delivery in the rhesus monkey. Biotechnol Bioeng. 2009 Oct 8; Amyloid Cancer  

Villemagne VL, Pike K, Pejoska S, Boyd A, Power M, Jones G, Masters CL, Rowe CC. ;{11}C-PiB PET A_{Bri} Imaging in Worster-Drought Syndrome (Familial British Dementia): A Case Report. J Alzheimers Dis. 2009 Oct 8; Amyloid Cancer  

Rudrabhatla P, Pant HC. Phosphorylation-Specific Peptidyl-Prolyl Isomerization of Neuronal Cytoskeletal Proteins by Pin1: Implications for Therapeutics in Neurodegeneration. J Alzheimers Dis. 2009 Oct 8; Amyloid Cancer  

Cui J, Chen Q, Yue X, Jiang X, Gao GF, Yu LC, Zhang Y. Galanin Protects Against Intracellular Amyloid Toxicity in Human Primary Neurons. J Alzheimers Dis. 2009 Oct 8; Amyloid Cancer  

von Bernhardi R. Immunotherapy in Alzheimer's Disease: Where Do We Stand? Where Should We Go? J Alzheimers Dis. 2009 Oct 8; Amyloid Cancer  

Diarra A, Patel A, Geetha T, Potter P, Babu JR. Signaling of the neurotrophin receptor p75 in relation to Alzheimer's disease. Biochem Biophys Res Commun. 2009 Oct 7; Amyloid Cancer  

Elsinghorst PW, Härtig W, Goldhammer S, Grosche J, Gütschow M. A gorge-spanning, high-affinity cholinesterase inhibitor to explore beta-amyloid plaques. Org Biomol Chem. 2009 Oct 7;7(19):3940-6. Amyloid Cancer  

Yang TT, Hsu CT, Kuo YM. Cell-derived soluble oligomers of human amyloid-beta peptides disturb cellular homeostasis and induce apoptosis in primary hippocampal neurons. J Neural Transm. 2009 Oct 7; Amyloid Cancer  

Meyer-Luehmann M, Mielke M, Spires-Jones TL, Stoothoff W, Jones P, Bacskai BJ, Hyman BT. A reporter of local dendritic translocation shows plaque- related loss of neural system function in APP-transgenic mice. J Neurosci. 2009 Oct 7;29(40):12636-40. Amyloid Cancer  

McCarty CE, Volicer L. Hospice Access for Individuals With Dementia. Am J Alzheimers Dis Other Demen. 2009 Oct 7; Amyloid Cancer  

Hedden T, Van Dijk KR, Becker JA, Mehta A, Sperling RA, Johnson KA, Buckner RL. Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J Neurosci. 2009 Oct 7;29(40):12686-94. Amyloid Cancer  

Wille H, Bian W, McDonald M, Kendall A, Colby DW, Bloch L, Ollesch J, Borovinskiy AL, Cohen FE, Prusiner SB, Stubbs G. Natural and synthetic prion structure from X-ray fiber diffraction. Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):16990-5. Amyloid Cancer  

Atamna H. Amino acids variations in Amyloid-beta peptides, mitochondrial dysfunction, and new therapies for Alzheimer's disease. J Bioenerg Biomembr. 2009 Oct 6; Amyloid Cancer  

Nehar S, Mishra M, Heese K. Identification and characterisation of the novel amyloid-beta peptide-induced protein p17. FEBS Lett. 2009 Oct 6;583(19):3247-53. Amyloid Cancer  

Hampel H, Shen Y, Walsh DM, Aisen P, Shaw LM, Zetterberg H, Trojanowski JQ, Blennow K. Biological markers of amyloid beta-related mechanisms in Alzheimer's disease. Exp Neurol. 2009 Oct 6; Amyloid Cancer  

Perucho J, Casarejos MJ, Rubio I, Rodriguez-Navarro JA, Gómez A, Ampuero I, Rodal I, Solano RM, Carro E, de Yébenes JG, Mena MA. The effects of parkin suppression on the behaviour, amyloid processing, and cell survival in APP mutant transgenic mice. Exp Neurol. 2009 Oct 6; Amyloid Cancer  

Price KA, Caragounis A, Paterson BM, Filiz G, Volitakis I, Masters CL, Barnham KJ, Donnelly PS, Crouch PJ, White AR. Sustained Activation of Glial Cell Epidermal Growth Factor Receptor by Bis(thiosemicarbazonato) Metal Complexes Is Associated with Inhibition of Protein Tyrosine Phosphatase Activity. J Med Chem. 2009 Oct 6; Amyloid Cancer  

Ran C, Xu X, Raymond SB, Ferrara BJ, Neal K, Bacskai BJ, Medarova Z, Moore A. Design, Synthesis, and Testing of Difluoroboron-Derivatized Curcumins as Near-Infrared Probes for in Vivo Detection of Amyloid-beta Deposits. J Am Chem Soc. 2009 Oct 6; Amyloid Cancer  

Davis CH, Berkowitz ML. Structure of the Amyloid-beta (1-42) Monomer Absorbed To Model Phospholipid Bilayers: A Molecular Dynamics Study. J Phys Chem B. 2009 Oct 6; Amyloid Cancer  

Serrano F, Chang A, Hernandez C, Pautler RG, Sweatt JD, Klann E. NADPH oxidase mediates beta-amyloid peptide-induced activation of ERK in hippocampal organotypic cultures. Mol Brain. 2009 Oct 5;2(1):31. Amyloid Cancer  

Takeda S, Sato N, Takeuchi D, Kurinami H, Shinohara M, Niisato K, Kano M, Ogihara T, Rakugi H, Morishita R. Angiotensin Receptor Blocker Prevented {beta}-Amyloid-Induced Cognitive Impairment Associated With Recovery of Neurovascular Coupling. Hypertension. 2009 Oct 5; Amyloid Cancer  

Yang X, Sheng W, He Y, Cui J, Haidekker MA, Sun GY, Lee JC. Secretory phospholipase A2 Type III enhances {alpha}-secretase-dependent amyloid precursor protein processing through alterations in membrane fluidity. J Lipid Res. 2009 Oct 5; Amyloid Cancer  

Jäger S, Leuchtenberger S, Martin A, Czirr E, Wesselowski J, Dieckmann M, Waldron E, Korth C, Koo EH, Heneka M, Weggen S, Pietrzik CU. alpha-secretase mediated conversion of the Amyloid Precursor Protein derived membrane stub C99 to C83 limits Abeta generation. J Neurochem. 2009 Oct 5; Amyloid Cancer  

Ye JT, Pi RB, Mao XX, Chen XH, Qin J, Xu SW, Liu PQ. Alterations in mRNA expression of BACE1, cathepsin B, and glutaminyl cyclase in mice ischemic brain. Neuroreport. 2009 Oct 3; Amyloid Cancer  

Surguchev A, Surguchov A. Conformational diseases: looking into the eyes. Brain Res Bull. 2009 Oct 3; Amyloid Cancer  

Mancuso M, Calsolaro V, Orsucci D, Siciliano G, Murri L. Is there a primary role of the mitochondrial genome in Alzheimer's disease? J Bioenerg Biomembr. 2009 Oct 2; Amyloid Cancer  

Ferrer I. Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease. J Bioenerg Biomembr. 2009 Oct 2; Amyloid Cancer  

Alikhani N, Ankarcrona M, Glaser E. Mitochondria and Alzheimer's disease: amyloid-beta peptide uptake and degradation by the presequence protease, hPreP. J Bioenerg Biomembr. 2009 Oct 2; Amyloid Cancer  

Porter AE, Knowles TP, Muller K, Meehan S, McGuire E, Skepper J, Welland ME, Dobson CM. Imaging amyloid fibrils within cells using a Se-labelling strategy. J Mol Biol. 2009 Oct 2;392(4):868-71. Amyloid Cancer  

Nemes Z, Petrovski G, Aerts M, Sergeant K, Devreese B, Fésüs L. Transglutaminase-mediated intramolecular cross-linking of membrane-bound alpha-synuclein promotes amyloid formation in Lewy bodies. J Biol Chem. 2009 Oct 2;284(40):27252-64. Amyloid Cancer  

Qin XY, Cheng Y, Cui J, Zhang Y, Yu LC. Potential protection of curcumin against amyloid beta-induced toxicity on cultured rat prefrontal cortical neurons. Neurosci Lett. 2009 Oct 2;463(2):158-61. Amyloid Cancer  

Tsukuda K, Mogi M, Iwanami J, Min LJ, Sakata A, Jing F, Iwai M, Horiuchi M. Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation. Hypertension. 2009 Oct;54(4):782-7. Amyloid Cancer  

Yazdanparast R, Shaykhalishahi H. Protective effect of a triazine-derivative (AA3E2) on beta-amyloid-induced damages in SK-N-MC cells. Toxicol In Vitro. 2009 Oct;23(7):1277-83. Amyloid Cancer  

Nuutinen T, Suuronen T, Kauppinen A, Salminen A. Clusterin: a forgotten player in Alzheimer's disease. Brain Res Rev. 2009 Oct;61(2):89-104. Amyloid Cancer  

Cecchi C, Nichino D, Zampagni M, Bernacchioni C, Evangelisti E, Pensalfini A, Liguri G, Gliozzi A, Stefani M, Relini A. A protective role for lipid raft cholesterol against amyloid-induced membrane damage in human neuroblastoma cells. Biochim Biophys Acta. 2009 Oct;1788(10):2204-16. Amyloid Cancer  

Lee JW, Lee YK, Ban JO, Ha TY, Yun YP, Han SB, Oh KW, Hong JT. Green tea (-)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice. J Nutr. 2009 Oct;139(10):1987-93. Amyloid Cancer  

Lu P, Mamiya T, Lu LL, Mouri A, Niwa M, Hiramatsu M, Zou LB, Nagai T, Ikejima T, Nabeshima T. Silibinin attenuates amyloid beta(25-35) peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-alpha in mice. J Pharmacol Exp Ther. 2009 Oct;331(1):319-26. Amyloid Cancer  

Buxbaum JN, Reixach N. Transthyretin: the servant of many masters. Cell Mol Life Sci. 2009 Oct;66(19):3095-101. Amyloid Cancer  

You X, Zhang YW, Chen Y, Huang X, Xu R, Cao X, Chen J, Liu Y, Zhang X, Xu H. Retinoid X receptor-alpha mediates (R )-flurbiprofen's effect on the levels of Alzheimer's beta-amyloid. J Neurochem. 2009 Oct;111(1):142-9. Amyloid Cancer  

Franco R, Cidlowski JA. Apoptosis and glutathione: beyond an antioxidant. Cell Death Differ. 2009 Oct;16(10):1303-14. Amyloid Cancer  

Schipper HM, Gupta A, Szarek WA. Suppression of Glial HO-1 Activitiy as a Potential Neurotherapeutic Intervention in AD. Curr Alzheimer Res. 2009 Oct 1; Amyloid Cancer  

Mitchell RM, Neafsey EJ, Collins MA. Essential involvement of the NMDA receptor in ethanol preconditioning-dependent neuroprotection from amyloid-betain vitro. J Neurochem. 2009 Oct;111(2):580-8. Amyloid Cancer  

Laky K, Annaert W, Fowlkes BJ. Amyloid precursor family proteins are expressed by thymic and lymph node stromal cells but are not required for lymphocyte development. Int Immunol. 2009 Oct;21(10):1163-74. Amyloid Cancer  

Tompa P. Structural disorder in amyloid fibrils: its implication in dynamic interactions of proteins. FEBS J. 2009 Oct;276(19):5406-15. Amyloid Cancer  

Hossain S, Hashimoto M, Katakura M, Miwa K, Shimada T, Shido O. Mechanism of docosahexaenoic acid-induced inhibition of in vitro Abeta1-42 fibrillation and Abeta1-42-induced toxicity in SH-S5Y5 cells. J Neurochem. 2009 Oct;111(2):568-79. Amyloid Cancer  

Sanchez-Ortiz E, Hahm BK, Armstrong DL, Rossie S. Protein phosphatase 5 protects neurons against amyloid-beta toxicity. J Neurochem. 2009 Oct;111(2):391-402. Amyloid Cancer  

Kalinin S, Richardson JC, Feinstein DL. A PPardelta Agonist Reduces Amyloid Burden and Brain Inflammation in a Transgenic Mouse Model of Alzheimer's Disease. Curr Alzheimer Res. 2009 Oct 1; Amyloid Cancer  

Sigurdsson EM. Tau-Focused Immunotherapy for Alzheimer's Disease and Related Tauopathies. Curr Alzheimer Res. 2009 Oct 1; Amyloid Cancer  

Chiba T, Yamada M, Aiso S. Targeting the JAK2/STAT3 axis in Alzheimer's disease. Expert Opin Ther Targets. 2009 Oct;13(10):1155-67. Amyloid Cancer  

Pereson S, Wils H, Kleinberger G, McGowan E, Vandewoestyne M, Van Broeck B, Joris G, Cuijt I, Deforce D, Hutton M, Van Broeckhoven C, Kumar-Singh S. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models. J Pathol. 2009 Oct;219(2):173-81. Amyloid Cancer  

Rami A. Review: autophagy in neurodegeneration: firefighter and/or incendiarist? Neuropathol Appl Neurobiol. 2009 Oct;35(5):449-61. Amyloid Cancer  

D'Arrigo C, Tabaton M, Perico A. N-terminal truncated pyroglutamyl beta amyloid peptide Abetapy3-42 shows a faster aggregation kinetics than the full-length Abeta1-42. Biopolymers. 2009 Oct;91(10):861-73. Amyloid Cancer  

Chen JQ, Cammarata PR, Baines CP, Yager JD. Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. Biochim Biophys Acta. 2009 Oct;1793(10):1540-70. Amyloid Cancer  

Sarkar N, Singh AN, Dubey VK. Effect of curcumin on amyloidogenic property of molten globule-like intermediate state of 2,5-diketo-D-gluconate reductase A. Biol Chem. 2009 Oct;390(10):1057-61. Amyloid Cancer  

Nornes S, Newman M, Wells S, Verdile G, Martins RN, Lardelli M. Independent and cooperative action of Psen2 with Psen1 in zebrafish embryos. Exp Cell Res. 2009 Oct 1;315(16):2791-801. Amyloid Cancer  

Boridy S, Takahashi H, Akiyoshi K, Maysinger D. The binding of pullulan modified cholesteryl nanogels to Abeta oligomers and their suppression of cytotoxicity. Biomaterials. 2009 Oct;30(29):5583-91. Amyloid Cancer  

Song H, Ritz S, Knoll W, Sinner EK. Conformation and topology of amyloid beta-protein adsorbed on a tethered artificial membrane probed by surface plasmon field-enhanced fluorescence spectroscopy. J Struct Biol. 2009 Oct;168(1):117-24. Amyloid Cancer  

Garbes L, Riessland M, Hölker I, Heller R, Hauke J, Tränkle C, Coras R, Blümcke I, Hahnen E, Wirth B. LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate. Hum Mol Genet. 2009 Oct 1;18(19):3645-58. Amyloid Cancer  

Mizoguchi H, Takuma K, Fukuzaki E, Ibi D, Someya E, Akazawa KH, Alkam T, Tsunekawa H, Mouri A, Noda Y, Nabeshima T, Yamada K. Matrix metalloprotease-9 inhibition improves amyloid {beta}-mediated cognitive impairment and neurotoxicity in mice. J Pharmacol Exp Ther. 2009 Oct;331(1):14-22. Amyloid Cancer  

Bürger S, Noack M, Kirazov LP, Kirazov EP, Naydenov CL, Kouznetsova E, Yafai Y, Schliebs R. Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and beta-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain. Int J Dev Neurosci. 2009 Oct;27(6):517-23. Amyloid Cancer  

Perez-Gracia E, Blanco R, Carmona M, Carro E, Ferrer I. Oxidative stress damage and oxidative stress responses in the choroid plexus in Alzheimer's disease. Acta Neuropathol. 2009 Oct;118(4):497-504. Amyloid Cancer  

Ahmad A, Muzaffar M, Ingram VM. Ca(2+), within the physiological concentrations, selectively accelerates Abeta42 fibril formation and not Abeta40 in vitro. Biochim Biophys Acta. 2009 Oct;1794(10):1537-48. Amyloid Cancer  

Leskovjan AC, Lanzirotti A, Miller LM. Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer's disease. Neuroimage. 2009 Oct 1;47(4):1215-20. Amyloid Cancer  

Yadav A, Sonker M. Perspectives in designing anti aggregation agents as Alzheimer disease drugs. Eur J Med Chem. 2009 Oct;44(10):3866-73. Amyloid Cancer  

Addis DR, Sacchetti DC, Ally BA, Budson AE, Schacter DL. Episodic simulation of future events is impaired in mild Alzheimer's disease. Neuropsychologia. 2009 Oct;47(12):2660-71. Amyloid Cancer  

Streit WJ, Braak H, Xue QS, Bechmann I. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol. 2009 Oct;118(4):475-85. Amyloid Cancer  

Ali AK, Banks WA, Kumar VB, Shah GN, Lynch JL, Farr SA, Fleegal-DeMotta MA, Morley JE. Nitric oxide activity and isoenzyme expression in the senescence-accelerated mouse p8 model of Alzheimer's disease: effects of anti-amyloid antibody and antisense treatments. J Gerontol A Biol Sci Med Sci. 2009 Oct;64(10):1025-30. Amyloid Cancer  

Harrison FE, Hosseini AH, McDonald MP, May JM. Vitamin C reduces spatial learning deficits in middle-aged and very old APP/PSEN1 transgenic and wild-type mice. Pharmacol Biochem Behav. 2009 Oct;93(4):443-50. Amyloid Cancer  

Wirths O, Breyhan H, Cynis H, Schilling S, Demuth HU, Bayer TA. Intraneuronal pyroglutamate-Abeta 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model. Acta Neuropathol. 2009 Oct;118(4):487-96. Amyloid Cancer  

Crews L, Tsigelny I, Hashimoto M, Masliah E. Role of synucleins in Alzheimer's disease. Neurotox Res. 2009 Oct;16(3):306-17. Amyloid Cancer  

Antequera D, Vargas T, Ugalde C, Spuch C, Molina JA, Ferrer I, Bermejo-Pareja F, Carro E. Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer's disease. Neurobiol Dis. 2009 Oct;36(1):42-50. Amyloid Cancer  

Dumont M, Ho DJ, Calingasan NY, Xu H, Gibson G, Beal MF. Mitochondrial dihydrolipoyl succinyltransferase deficiency accelerates amyloid pathology and memory deficit in a transgenic mouse model of amyloid deposition. Free Radic Biol Med. 2009 Oct 1;47(7):1019-27. Amyloid Cancer  

Epelbaum J, Guillou JL, Gastambide F, Hoyer D, Duron E, Viollet C. Somatostatin, Alzheimer's disease and cognition: an old story coming of age? Prog Neurobiol. 2009 Oct;89(2):153-61. Amyloid Cancer  

Harada R, Kobayashi N, Kim J, Nakamura C, Han SW, Ikebukuro K, Sode K. The effect of amino acid substitution in the imperfect repeat sequences of alpha-synuclein on fibrillation. Biochim Biophys Acta. 2009 Oct;1792(10):998-1003. Amyloid Cancer  

Zhou YQ, Yang ZL, Xu L, Li P, Hu YZ. Akebia saponin D, a saponin component from Dipsacus asper Wall, protects PC 12 cells against amyloid-beta induced cytotoxicity. Cell Biol Int. 2009 Oct;33(10):1102-10. Amyloid Cancer  

Jin HK, Bae JS, Furuya S, Carter JE. Amyloid beta-derived neuroplasticity in bone marrow-derived mesenchymal stem cells is mediated by NPY and 5-HT2B receptors via ERK1/2 signalling pathways. Cell Prolif. 2009 Oct;42(5):571-86. Amyloid Cancer  

Abad C, Martínez-Gil L, Tamborero S, Mingarro I. Membrane topology of gp41 and amyloid precursor protein: Interfering transmembrane interactions as potential targets for HIV and Alzheimer treatment. Biochim Biophys Acta. 2009 Oct;1788(10):2132-41. Amyloid Cancer  

Mattson MP. Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Exp Gerontol. 2009 Oct;44(10):625-33. Amyloid Cancer  

Kern A, Behl C. The unsolved relationship of brain aging and late-onset Alzheimer disease. Biochim Biophys Acta. 2009 Oct;1790(10):1124-32. Amyloid Cancer  

Saluja I, Paulson H, Gupta A, Turner RS. X11alpha haploinsufficiency enhances Abeta amyloid deposition in Alzheimer's disease transgenic mice. Neurobiol Dis. 2009 Oct;36(1):162-8. Amyloid Cancer  

Morel M, Couturier J, Pontcharraud R, Gil R, Fauconneau B, Paccalin M, Page G. Evidence of molecular links between PKR and mTOR signalling pathways in Abeta neurotoxicity: role of p53, Redd1 and TSC2. Neurobiol Dis. 2009 Oct;36(1):151-61. Amyloid Cancer  

Taniguchi A. [Development of click peptide: stimuli-responsive precursor producing Alzheimer's disease-related amyloid beta peptide] Yakugaku Zasshi. 2009 Oct;129(10):1227-32. Amyloid Cancer  

Ono M. Development of positron-emission tomography/single-photon emission computed tomography imaging probes for in vivo detection of beta-amyloid plaques in Alzheimer's brains. Chem Pharm Bull (Tokyo). 2009 Oct;57(10):1029-39. Amyloid Cancer  

Mastrangelo MA, Sudol KL, Narrow WC, Bowers WJ. Interferon-{gamma} Differentially Affects Alzheimer's Disease Pathologies and Induces Neurogenesis in Triple Transgenic-AD Mice. Am J Pathol. 2009 Oct 1; Amyloid Cancer  

Terbach N, Williams RS. Structure-function studies for the panacea, valproic acid. Biochem Soc Trans. 2009 Oct;37(Pt 5):1126-32. Amyloid Cancer  

Harrison FE, Allard J, Bixler R, Usoh C, Li L, May JM, McDonald MP. Antioxidants and cognitive training interact to affect oxidative stress and memory in APP/PSEN1 mice. Nutr Neurosci. 2009 Oct;12(5):203-18. Amyloid Cancer  

Han F, Fukunaga K. beta-Amyloid Accumulation in Neurovascular Units Following Brain Embolism. J Pharmacol Sci. 2009 Oct;111(2):101-9. Amyloid Cancer  

Pickrell AM, Fukui H, Moraes CT. The role of cytochrome c oxidase deficiency in ROS and amyloid plaque formation. J Bioenerg Biomembr. 2009 Oct 1; Amyloid Cancer  

Berridge MJ. Calcium hypothesis of Alzheimer's disease. Pflugers Arch. 2009 Oct 1; Amyloid Cancer  

Brunden KR, Trojanowski JQ, Lee VM. Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies. Nat Rev Drug Discov. 2009 Oct;8(10):783-93. Amyloid Cancer  

Ono M, Hayashi S, Kimura H, Kawashima H, Nakayama M, Saji H. Push-pull benzothiazole derivatives as probes for detecting beta-amyloid plaques in Alzheimer's brains. Bioorg Med Chem. 2009 Oct 1;17(19):7002-7. Amyloid Cancer  

Kristofiková Z, Bocková M, Hegnerová K, Bartos A, Klaschka J, Rícný J, Rípová D, Homola J. Enhanced levels of mitochondrial enzyme 17beta-hydroxysteroid dehydrogenase type 10 in patients with Alzheimer disease and multiple sclerosis. Mol Biosyst. 2009 Oct;5(10):1174-9. Amyloid Cancer  

Maeda T, Marutani T, Zou K, Araki W, Tanabe C, Yagishita N, Yamano Y, Amano T, Michikawa M, Nakajima T, Komano H. An E3 ubiquitin ligase, Synoviolin, is involved in the degradation of immature nicastrin, and regulates the production of amyloid beta-protein. FEBS J. 2009 Oct;276(20):5832-40. Amyloid Cancer  

Passos GF, Figueiredo CP, Prediger RD, Pandolfo P, Duarte FS, Medeiros R, Calixto JB. Role of the macrophage inflammatory protein-1alpha/CC chemokine receptor 5 signaling pathway in the neuroinflammatory response and cognitive deficits induced by beta-amyloid peptide. Am J Pathol. 2009 Oct;175(4):1586-97. Amyloid Cancer  

Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fiévet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, European Alzheimer's Disease Initiative Investigators, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossù P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanché H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alpérovitch A, Lathrop M, Amouyel P. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet. 2009 Oct;41(10):1094-9. Amyloid Cancer

St-Amour I, Laroche A, Bazin R, Lemieux R. Activation of cryptic IgG reactive with BAFF, amyloid beta peptide and GM-CSF during the industrial fractionation of human plasma into therapeutic intravenous immunoglobulins. Clin Immunol. 2009 Oct;133(1):52-60. Amyloid Cancer  

Okereke OI, Xia W, Selkoe DJ, Grodstein F. Ten-year change in plasma amyloid beta levels and late-life cognitive decline. Arch Neurol. 2009 Oct;66(10):1247-53. Amyloid Cancer  

Ghoshal N, Cali I, Perrin RJ, Josephson SA, Sun N, Gambetti P, Morris JC. Codistribution of amyloid beta plaques and spongiform degeneration in familial Creutzfeldt-Jakob disease with the E200K-129M haplotype. Arch Neurol. 2009 Oct;66(10):1240-6. Amyloid Cancer  

Subscribe to Amyloid et.al. by Email